| CTRI Number |
CTRI/2025/03/083060 [Registered on: 21/03/2025] Trial Registered Prospectively |
| Last Modified On: |
19/03/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cohort Study |
| Study Design |
Other |
|
Public Title of Study
|
Understanding development of osteoarthritis subsequent to injury to knee joint |
|
Scientific Title of Study
|
A study on association of inflammatory ,genetic and epigenetic markers with Kellgren Lawrence grading in post traumatic osteoarthritis of knee |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Keerthy Rethinam M |
| Designation |
PhD scholar |
| Affiliation |
Sri Ramachandra Institute of higher education and research |
| Address |
Department of Biochemistry
3F wing ,Third floor ,
Medical college building,
Sri Ramachandra institute of higher education ,Porur
Chennai TAMIL NADU 600116 India |
| Phone |
9597790738 |
| Fax |
|
| Email |
keerthyrethinamm@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Santhi Silambanan |
| Designation |
Professor |
| Affiliation |
Sri Ramachandra Institute of higher education and research |
| Address |
Department of Biochemistry
3E wing ,Third floor ,
Medical college building ,
Sri ramachandra institute of higher education and research
Porur
Chennai TAMIL NADU 600116 India |
| Phone |
09597790738 |
| Fax |
|
| Email |
santhisilambanan@sriramachandra.edu.in |
|
Details of Contact Person Public Query
|
| Name |
Santhi Silambanan |
| Designation |
Professor |
| Affiliation |
Sri Ramachandra Institute of higher education and research |
| Address |
Department of Biochemistry
3E wing, Third floor ,
Medical college building ,
Sri ramachandra institute of higher education and research
Porur
Chennai TAMIL NADU 600116 India |
| Phone |
09597790738 |
| Fax |
|
| Email |
santhisilambanan@sriramachandra.edu.in |
|
|
Source of Monetary or Material Support
|
| Indian council of medical research (ICMR),
V .Ramalingaswami Bhawan,
P.O.Box no -4911,
Ansari nagar ,
New delhi -110029
India |
|
|
Primary Sponsor
|
| Name |
Indian council of medical research ICMR |
| Address |
V.Ramalingaswami bhawan,
P.O .Box no : 4911,
Ansari nagar
New delhi-110029,
India |
| Type of Sponsor |
Government funding agency |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Keerthy Rethinam M |
SRIHER |
Department of sport medicine and arthroscopy & department of biochemistry
3E ,third floor
SRIHER
Porur
Chennai
Chennai TAMIL NADU |
9597790738 04424767008 keerthyrethinamm@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M15-M19||Osteoarthritis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
NIL |
NIL |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Both |
| Details |
H/O Knee injury within 3 months |
|
| ExclusionCriteria |
| Details |
History auto immune diseases
Any ohter chronic medical ilness
Post menopausal women
H/O Viscosupplementaion or vit D |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| We can initiate treatment and screening procedures in handling osteoarthritis subsequent to trauma |
Baseline,6 months and 12 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Normal joint or OA joint |
12 months |
|
|
Target Sample Size
|
Total Sample Size="170" Sample Size from India="70"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
19/04/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="5" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Open to Recruitment |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response (Others) - Similar type of studies
- By what mechanism will data be made available?
Response - Proposals should be directed to [keerthyrethinamm@gmail.com].
- For how long will this data be available start date provided 01-06-2025 and end date provided 01-06-2030?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
The study participants are inducted into the study after getting written informed consent. They are identified by the consultants in the departments of Arthroscopy and Sports medicine. Individuals in the age group of 20-50 years who give history of injury to the knee joints in less than 3 months are included. All the participants are subjected to clinical examination, objective pain scoring, standard knee outcome score visual-analogue scale (VAS) and WOMAC .X ray will be taken .Blood and urine samples will be collected.The samples will be analysed for biomarkers .Statistical analysis will be done . |